KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Gains from Investment Securities (2016 - 2025)

Jazz Pharmaceuticals has reported Gains from Investment Securities over the past 16 years, most recently at $139.8 million for Q4 2025.

  • Quarterly Gains from Investment Securities rose 608.07% to $139.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $121.8 million through Dec 2025, up 777.54% year-over-year, with the annual reading at $121.8 million for FY2025, 777.54% up from the prior year.
  • Gains from Investment Securities was $139.8 million for Q4 2025 at Jazz Pharmaceuticals, up from -$11.0 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $232.1 million in Q4 2023 and troughed at -$101.7 million in Q3 2023.
  • The 5-year median for Gains from Investment Securities is $3.8 million (2022), against an average of $16.6 million.
  • Peak annual rise in Gains from Investment Securities hit 9463.69% in 2022, while the deepest fall reached 4455.15% in 2022.
  • Tracing JAZZ's Gains from Investment Securities over 5 years: stood at $6.0 million in 2021, then skyrocketed by 74.7% to $10.5 million in 2022, then surged by 2115.1% to $232.1 million in 2023, then crashed by 111.86% to -$27.5 million in 2024, then soared by 608.07% to $139.8 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $139.8 million, -$11.0 million, and -$7.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.